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ABSTRACT
Background: Fibromyalgia syndrome is a disorder that is associated with significant 
morbidity.  Despite its existence worldwide there is hardly any epidemiological data 
in Africa and none in Kenya. 
Objectives: To determine the prevalence of fibromyalgia, chronic regional pain and 
chronic widespread pain in patients attending the medical outpatient and rheumatology 
clinic at Kenyatta National Hospital and to investigate the frequency of fibromyalgia 
symptoms and  to document the primary diagnosis and cormobid conditions in the 
these patients.
Design: A Cross sectional descriptive study. 
Setting: The medical outpatient and rheumatology clinic at The Kenyatta National 
Hospital.
Subjects: Three hundred and eighty four patients with musculoskeletal pain. 
Results: The prevalence of fibromyalgia, chronic regional pain and chronic widespread 
pain amongst patients with chronic musculoskeletal pain (n = 384) in the medical 
outpatient clinic and rheumatology clinic of Kenyatta National Hospital was 13% (n = 
50), 76% (n = 291) and 11% (n = 43) respectively. The overall three month prevalence of 
fibromyalgia in the general medical outpatient clinic was 1% , chronic widespread pain 
1.2% and chronic regional pain 6.7% .The mean age of patients with fibromyalgia was 
48.5 years SD 2.6 [95%CI 43.1-53.8]. There was a female predominance of 97.7% (n = 42). 
Mean duration of illness was 5.8 years SD 0.8 [95%CI 4.1 - 7.4]. Rheumatoid arthritis 
was the most frequent primary diagnosis at first consultation in the clinics [30.2% 
(n=13/43)]. Hypertension was the most common cormobid disease [53.5 %( n=23/43)] 
The mean total FIQR score for fibromyalgia patients was 55.94% SD (2.85)95%CI 
50.19-61.68. The most frequent symptoms were pain, fatigue, stiffness, depression, 
and unrefreshing sleep while balance problems, headache and increased sensitivity 
to the environment were the least reported symptoms.
Conclusion: Fibromyalgia is prevalent among patients with musculoskeletal complains 
in the medical outpatient and rheumatology clinics at the Kenyatta National Hospital. 
These patients frequently have other cormobid illnesses and the primary diagnosis is 
often missed. Therefore, there is need to sensitise care givers on this condition.
INTRODUCTION
Fibromyalgia (FM) is a disorder characterised by 
widespread musculoskeletal pain and tenderness at 
specific points of the body. Patients with fibromyalgia 
also tend to experience other symptoms like sleep 
disturbances, fatigue and others, the severity of which 
can be measured by the revised fibromyalgia impact 
questionaire (4).  The diagnosis of fibromyalgia has 
evolved over many years and the 1990 American 
college of rheumatology [ACR] criteria have been 
in use until recently (2010) when the ACR produced 
preliminary criteria (5).
 Little is known about the epidemiology of 
fibromyalgia in Kenya and Africa at large. Its burden 
in the health sector is equally unknown. Studies in 
Canada and United States of America have shown 
that FM patients use about twice the health services 
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compared to patients with other diseases (1). In 
addition to that, the total healthcare cost of FM is 
three times higher in the patients compared with 
controls (2). This is probably because these patients 
display a higher prevalence of co-morbidities than 
the rest of the population, have a higher average of 
work days missed, and commonly report a higher 
use of pain-related medication (3). The burden of 
fibromyalgia has been found to be comparable to 
that of rheumatoid arthritis and the total costs are 
double for patients with both conditions.
  In our clinical setting, the burden of this 
syndrome is unknown. Given the  high economic 
burden, significant morbidity and ongoing disability 
that has been described in patients with FM, there was 
need to document the prevalence in our outpatient 
setting. It was also important to describe the clinical 
characteristics of these patients in our geographic 
region in order to document any variability in clinical 
presentation. This was a descriptive study intended 
to provide a baseline for other studies on the subject 
in this region. The study will increase awareness of 
this syndrome locally amongst the health practitioners 
and also affected patients and caregivers.
MATERIALS AND METHODS
Our research question was to study the prevalence 
and clinical pattern of FM in the medical outpatients 
at the Kenyatta National Hospital (KNH). The 
broad objective was to determine the prevalence 
and characteristics of patients with FM. Our specific 
objectives were; to determine the demographic 
characteristics of patients with FM, to assess the 
frequency of FM-related symptoms (for example 
fatigue, stiffness and others); to document the 
associated co-mobidities and to document the primary 
(initial) diagnosis of patients with FM.The secondary 
objectives were to determine the prevalence of chronic 
regional pain and chronic widespread pain.
 The study design was a descriptive cross sectional 
study. we carried out the study at the KNH general 
medical out patient clinics ( MOPC )and rheumatology 
clinics.
 The MOPC is not only a tertiary point of care 
for referral cases from around the country but also 
acts as a primary point of care for Nairobi and its 
environment. 
 The rheumatology clinic started operations in 
March 2010. Prior to this the rheumatology patients 
were being handled from the various MOPC clinics. 
The clinic cares for an average of 26 patients with 
various rheumatological conditions per week. It is 
run by rheumatologists, physicians and postgraduate 
students.
  The study population included medical 
outpatients and rheumatology patients with 
musculoskeletal pain of more than three months, 
aged more than 18 years, had undergone outpatient 
follow-up for at least three months, and had given 
informed consent. we excluded patients with 
abnormal neurological examination and documented 
malignancies. Consecutive sampling was done. 
Sample size : A total of 384 patients with musculoskeletal 
pain were interviewed. The screening and enrollment 
was done over three month duration. Patient 
confidentiality was maintained through the process 
and duplication was avoided by using serial numbers 
on the questionnaires.
Data collection tools and methods : A pretested 
questionnaire designed for the study containing 
socio-demographic factors, the American College 
of Rheumatology (ACR), 1990 criteria for the 
classification of FM (50), and the Revised FM Impact 
Questionnaire (FIQR) (4) were administered to all 
patients with musculoskeletal pain included in the 
study. The ACR criteria were used to establish patients 
with chronic widespread pain. Those who did not 
satisfy the criteria for widespread pain on all four 
quadrants of the body + axial skeleton were labeled 
as having chronic regional pain. 
 A physical exam and a tender point count were 
performed on all patients with musculoskeletal pain. 
Tenderness on all the 18 points was elicited by means of 
digital palpation. Force was applied of approximately 
four kilograms (to blanch the examiners fingers). 
Those, who satisfied the ACR criteria 1990 of chronic 
widespread pain plus 11/18 tender points, were 
diagnosed to have FM and were referred for specialist 
medical care and a review by the rheumatologist both 
for validation purposes and for follow-up. 
 The Revised FM Impact questionnaire (FIQR) 
was used to assess the frequency of FM symptoms and 
their severity.  The frequency of other symptoms of 
fibromyalgia for example, headache parasthaesia and 
subjective joint swelling (not captured in the FIQR) 
for the previous one month were also recorded.
 Data for questionnaires were collected during 
normal outpatient visits. The medical history, primary 
diagnosis, investigation results, and other relevant 
details were abstracted from the patient’s medical 
records.
 Data were entered into a computer using an 
Epi-info data entry programme. Analysis was done 
using the SPSS version 17.0 data analysis programme. 
The data were presented in tables and figures 
where applicable. Prevalence was determined as a 
percentage of the number of patients presenting in 
the medical outpatient and rheumatology clinics.
Continuous data were presented as means, standard 
deviations, medians, proportions and frequencies, 
while categorical data were presented in proportions, 
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frequencies and percentages. P-value of less than 5% 
(P<0.05) was considered statistically significant.
Study Variables : The independent variables were: 
Tender point count. (0-18†); Fatigue. (0-10†); Pain. 
(0-10†); Morning stiffness. (0-10†); Depression. (0-10†); 
Anxiety, (0-10†)  ; Insomnia. (0-10); Headache; Parast-
haesia; Subjective joint swelling; Memory problems 
(0-10); Level of tenderness to touch (0-10); Balance 
problems (0-10); Increased sensitivity to environment. 
(Cold, loud noises, odours bright colours and others) 
(0-10); Demographic characteristics; age, gender, oc-
cupation, marital status; Primary diagnosis at first 
consultation; associated co-mobidities.
 The dependent variables were; chronic wide-
spread pain; chronic regional pain; FM, (%). The ten 
point scoring scales were according to the revised 
fibromyalgia impact questionaire (FIQR). 
RESULTS
A total of 4310 files were reviewed from January 15th to 
April 15th  2011. Seven hundred and forty five patients 
had documentation of musculoskeletal complaints in 
the files. Upon verification only 384 patients satisfied 
the eligibility criteria as shown on Figure 1 and were en-
rolled.  Of the 384 patients with chronic musculoskeletal 
complaints, 232 (60.4%) patients were derived from the 
rheumatology clinic and 152 (39.5%) patients were from 
the medical outpatient clinics. The results presented were 
a combined analysis of data from the two clinics.
 Amongst the 384 patients with chronic musculo-
skeletal complaints, 43 patients satisfied the criteria for 
fibromyalgia, 50 patients satisfied the criteria for chronic 
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 The overall three month prevalence of FM in 
the general medical outpatient and rheumatology 
clinics was 1% n = (43/4310). Chronic widespread 
pain and chronic regional pain had prevalences of 
1.2 and 6.7% respectively.
 Prevalence rates of FM, chronic widespread pain 
and chronic regional pain in patients with chronic 
musculoskeletal complaints were 11.2, 13 and 75.5% 
respectively. 
 Table1 depicts the demographic characteristics 
of patients with FM. The sub-group of patients that 
satisfied the criteria for FM was younger compared to 
the rest of the study patients who had musculoskeletal 
complaints. However, this was not significant, p= 
0.09 . Their mean age was 48.46 years and majority 
belonged to the 40-49 year age groups (95% CI 26.5.-
57.2).  Only one male patient satisfied the criteria for 
FM while the rest were females. Even though many 
of the patients were married, [19 (44.2%) 95% CI 28.7-
59.7] an equally large proportion of these patients were 
widowed [15 (34.9%) 95% CI 20.-49.7]. More than half 
of the FM patients were unemployed [22 (51.2%) 95% 
CI 35.6-66.3] and a large number 20 (46.5 %) 95% CI 
30.9-62 were involved in daily manual activities. 
       Table1
Demographic characteristics of fibromyalgia patients (n=43)
Characteristic Factor Level N (%) 95% CI
Age (in years) < 307  (16.3)  4.8-27.8
 30-39 1 (2.3) 2.4-7.1
 40-49  18 (41.8) 26.5-57.2
 50-59  6 (13.9) 3.2-24.7
 60-69  6 (13.9)  3.2-24.7
 70+  5 (11.6)  1.6-21.6
Sex Female 42 (97.7) -
 male 1 (2.3) -
Marital Status Single  9 (20.9) 8.3-33.6
 Married  19 (44.2)  28.7-59.7
 widowed  15 (34.9)  20.0-49.7  
 divorced  0  0 
Daily activity type Manual  20 (46.5)  30.9-62.0
 Office  5 (11.6)  1.6-21.6
 neither  18 (41.9) 26.5-57.2
Type of Employment employed  1 (2.3)  2.4-7.0
 Self-employed  17 (39.5)  24.3-54.8
 Unemployed  22 (51.2) 35.6-66.3  
 Retired  3 (7.0) 0.9-14.9
Table 2




Median Age Years (25%-75%) 48.0(40.0-65.0)
Mean duration of illness Years (SD) 95%CI 5.8(0.81), 4.1-7.4
Median duration of illness Years 
( 25% -  75% ) 4.0(2.0-10.0)
Mean tender point count 11
Median tender point 25%-75% 11(11-14)
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Documented primary (initial) diagnosis: Approximately 
thirty percent [30.2 %( n=13)] of the patients who 
satisfied the criteria for FM had a primary diagnosis of 
rheumatoid arthritis documented.  Fourteen percent 
Table 3
Documented primary (initial) diagnosis in patients with fibromyalgia (n=43)
Primary Diagnosis Frequency Percent












(n=6) had no initial diagnosis and 14 %( n=6) had 
osteoarthritis. Only 9.3% (n=4) patients with FM had 
an initial exclusive diagnosis of FM documented . 
Documented co-mobidities: Hypertension was the 
most common documented co-mobidity at 53.5% 
[n=23/43]. Nineteen patients with FM 44.2% had no 
co-mobidity and one patient had a psychosomatic 
disorder.
Frequency of fibromyalgia symptoms: The frequency of 
FM symptoms as assessed by the revised FM impact 
questionaire (FIQR) are outlined in Table 4.
Table 5 outlines the frequency of other FM symptoms 
currently not assessed by the FIQR.Pain, fatigue, 
stiffness and depression were the most frequent 
symptoms while the least reported symptoms were 
balance problems, headache and increased sensitivity 
to environmental stimuli.
Table 4
Frequency of fibromyalgia Symptoms assessed by the 










Tenderness to touch 81.4
Balance problems 53.8
Increased sensitivity 
to environmental stimuli 65.1
Table 5
Frequency of other symptoms
symptom N(%)
Headache  27 (62.8)
Paresthaesia  30 (69.8)
Subjective joint swelling  32 (74.4)
Frequency of FM symptoms based on severity: Table 6 
outlines the frequency of FM symptoms according 
to the severity scores on the FM impact questionaire. 
All patients with FM (100%) reported having had 
pain in the previous seven days. Seventy two percent 
of fibromyalgia patients (n = 31) had pain scores of 
above seven on the FIQR symptom domain while 
none of them were found to have pain scores of less 
than four, almost a half (48.8 %) n= 21 of the patients 
with FM scored more than seven on the fatigue score 
and 62.8 % (n = 27) reported high unrefreshing sleep 
scores of more than seven. There were equally high 
depression scores in FM patients. Seventy five percent 
(n = 22) scored more than four on the visual analogue 
scale and 32.6% (n = 14) scored more than seven. 
Severe memory deficits and anxiety scores of more 
than seven were reported in 41.8 % (n =18) and 37.2 
% (n= 17) of patients respectively.
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Table 6
Frequency of fibromyalgia symptoms according to the FIQR symptom severity scores (1-10)
Symptom category None  1-3  4-6  7plus
 N (%) N (%) N (%) N (%)
pain 0 0 12 (27.9) 31 (72.1)
fatigue 4 (9.3) 3 (6.9) 15 (34.9) 21 (48.8)
stiffness 2 (4.7) 12 (27.9) 16 (37.2) 13 (30.2)
Unrefreshing sleep 4 (9.3) - 8 (18.6) 27 (62.8)
depression 3 (6.9) 8 (18.6) 18 (41.9) 14 (32.6)
memory 8 (18.6) 5 (11.6) 12 (27.9) 18 (41.8)
anxiety 11 (25.6) 2 (4.7) 14 (32.6) 16 (37.2)
Tenderness to touch 8 (18.6) 7 (16.3) 14 (32.6) 14 (32.6)
Balance problems 19 (44.2) 4 (9.3) 12 (27.9) 8 (18.6)
Increased sensitivity to touch 15 (34.9) 5 (11.6) 10 (23.3) 13 (30.2)
FIQR scores: Table 7 shows the total revised FM impact 
questionaire scores and the sub total scores for the 
function, impact and symptom domains.
 The mean scores for FM were; function score of 
15.9, impact score of 13.74 and symptom score of 26.29. 
The mean total FIQR score was 55.9 SD (18.6) Table 7. 
Table 7
Total FIQR scores
scores mean Std. Err. 95%   
   confidence     
   interval
Function score 
Total = 30 15.90 1.19 13.49 -18.32
Impact score
Total = 20 13.74 .601 12.53 - 14.96
Symptom subtotal
Total = 50 26.29 1.33 23.62 – 28.89
Total scores
Total =100 55.94 2.85 50.19 - 61.68 
The median FIQR score in fibromyalgia patients was 60.5 (52 - 69.2) 
Figure 2 is a histograph showing a gradual peak of the total FIQR scores at 58/100 with 31 out of the 43 FM 
patients having scores of above 50 out of the total 100 scores.
Figure 2  
Histograph of the total FIQR Scores
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DISCUSSION
Comparative studies carried out in the general medical 
outpatient clinics are lacking. In addition to this , we 
do not have comparative data from sub-Saharan 
African countries. we  chose to carry out this study 
from the general medical outpatient clinics because 
our rheumatology clinic had just started operating 
and prior to its inception all the rheumatology 
patients were being followed up from the various 
medical outpatient clinics. Furthermore FM is known 
to co-exist with other disorders seen commonly in 
the medical outpatient clinic. we also expected to 
find patients with FM in the rheumatology clinic 
because FM may co-exist with some rheumatology 
conditions. The overall three month prevalence of FM 
in MOPC and rheumatology clinic was 1%.  Amongst 
patients with chronic musculoskeletal complains, 
(n=384) the prevalence of FM (n=43) was 11.2%. 
This prevalence is much lower when compared with 
studies that have been done in rheumatology clinics. 
Our FM patients were younger than what has been 
observed in other studies  by wolfe et al in wichita 
Kansas USA (6) and  Branco et al in a study done in 
five European countries (7). None of these studies 
have been done in the sub-Saharan Africa therefore, 
we need community studies to ascertain the true age 
affected by FM in our set up.
 The female predominance has been a consistent 
finding seen in studies done in the community, the 
clinic setting and also in hospitalised patients (8, 9). 
 More than half of the FM patients were unemployed 
[22 (51.2%) 95% CI 35.6-66.2] and many of them 20 
(46.5 %) 95% CI 30.9-62 engaged in manual activities. 
Unemployment is a psychological stressor and 
frequent manual activities are possible risk factors 
that could have predisposed these patients to FM. 
However our study was descriptive in nature and we 
did not look for possible risk associations of FM. 
 One of our limitations was that the primary 
(initial) diagnosis and the co-mobid conditions 
were dependent on the documentation of the same 
in the patient’s files. No laboratory tests were done 
to confirm the different diagnoses. This was due to 
financial constraints. However, it is not routinely 
recommended to perfom various laboratory or 
radiological tests for the diagnosis of FM.
Thirty and fourteen percent of our patients had a 
primary (initial) diagnosis of rheumatoid arthritis and 
osteoarthritis documented respectively. It is possible 
for FM to co-exist with other rheumatology diseases 
as findings by Naranjo et al (10).
 Patients with FM usually present with multiple 
symptoms. This may cause difficulty in making a 
primary (initial) diagnosis and that could explain 
why 14 % of our patients with FM had no initial 
diagnosis of the 43 FM patients, only 9.3 %( 4) had 
a primary diagnosis of FM documented in the files. 
This is because FM is poorly understood. A study 
done in Tunisia assessing the level of knowledge, 
attitudes and practices of Tunisian physicians, and 
general practitioners concerning FM found that it 
was recognised as a clinical entity by  only 26.7% of 
their physicians (11). It would be of interest to study 
the knowledge of physicians about this disorder in 
this region.
 Hypertension was the most common documented 
co-mobidity at 53% [n=23/43]. There are no 
comparative studies done in the general medical 
outpatient clinic, therefore, we refer to a study done 
in the internal medicine wards at Soroka Medical 
Centre in Israel by Buskila et al (9). In this study, 
ischaemic heart disease was the most common cause 
of hospitalisation in FM patients, and only 9% was 
attributed to hypertension. with the high prevalence 
of hypertension in our patients with FM in the medical 
outpatient clinic, it would be prudent to look for other 
cardiovascular risk factors in these patients bearing in 
mind that Loevinger et al (12) found that women with 
chronic pain from fibromyalgia were at an increased 
risk for metabolic syndrome, which may be associated 
with relatively elevated norepinephrine levels in 
conjunction with relatively reduced epinephrine and 
cortisol secretion. 
 Majority of these patients also had severe 
symptoms as reported on the visual analogue scale. 
The high pain scores in FM are an expected finding 
because these patients have an increased central 
pain processing and a depressed endogenous pain 
inhibition. High depression rates are equally expected 
and this has been a persistent finding from both 
hospital and community based studies reporting 
depression prevalence rates that are up to five times 
higher in FM patients compared to other patients and 
three times higher than normal populations (14).
 Lack of refreshing sleep is common in FM and 
this usually leads to increased day time fatigue. Belt 
et al studying sleep problems in FM and rheumatoid 
arthritis (RA) compared with the general population 
and found that patients with FM and RA slept fewer 
hours a day than the general population. The FM 
patients reported more insomnia, less contentment 
with sleep and lack of deep and restful sleep in 
comparison with the RA patients and the participants 
of the population study. The FM patients also reported 
significantly more depression and pain than the RA 
patients. It was still shown in a logistic regression 
analysis that insomnia was almost five times more 
frequent in FM patients than in RA patients, even 
when adjustments were made for depression and 
pain (15). In addition to sleep problems, Naranjo et 
al found higher disability scores in patients who had 
both FM and RA and FM alone (10). 
 There are several limitations we encountered 
while using the FIQR. The symptom scoring of the 
Revised Fibromyalgia Impact questionnaire does not 
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indicate (on a scale of 0 -10) the level of a symptom 
score that is significant for that particular symptom. 
However, the overall total FIQR scores have been 
used in the interpretation of our data. Secondly the 
reporting of the   frequency and severity of the FM 
symptoms by the patients could have been subjective 
and a recall bias cannot be ruled out. Despite these 
limitations, our mean total FIQR scores of 55.94 [SD2.85 
95%CI 50.19 - 61.68] almost compares to findings by 
Bennet et al who found a mean (Fibromyalgia Impact 
Questionaire) FIQR score of 56.6 ± 19.9 in a validation 
study of the FIQR (4).
In conclusion, FM is most common among patients 
with musculoskel complaints in the medical outpatient 
and rheumatology clinic at KNH. It is associated 
with multiple co-mobid illnesses and patients often 
present with severe FM symptoms. This severity of 
symptoms could result in a high burden of disease 
and reduced quality of life, yet diagnosis is often 
not sought for. we, therefore, recommend increased 
awareness of medical personnel on the diagnosis and 
management of FM in order to improve diagnosis. 
There is also a need to actively assess for fibromyalgia 
in patients with chronic musculoskel complaints in the 
medical outpatient clinics.Finally the management of 
depression, fatigue and unrefreshing sleep should be 
emphasised in patients who have FM because these 
are the most common severe symptoms.
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